KDR and pancreatic neoplasm: Unexpectedly, the report disclosed an increase in phospho-Smad2-Ser465/467 and phospho-VEGFR2-Tyr1175 in the pancreatic tumor lysates from the OP treated cohort compared to the untreated cohort [34].